» Articles » PMID: 37804855

Understanding Diabetes Heterogeneity: Key Steps Towards Precision Medicine in Diabetes

Overview
Specialty Endocrinology
Date 2023 Oct 7
PMID 37804855
Authors
Affiliations
Soon will be listed here.
Abstract

Diabetes is a highly heterogeneous condition; yet, it is diagnosed by measuring a single blood-borne metabolite, glucose, irrespective of aetiology. Although pragmatically helpful, disease classification can become complex and limit advances in research and medical care. Here, we describe diabetes heterogeneity, highlighting recent approaches that could facilitate management by integrating three disease models across all forms of diabetes, namely, the palette model, the threshold model and the gradient model. Once diabetes has developed, further worsening of established diabetes and the subsequent emergence of diabetes complications are kept in check by multiple processes designed to prevent or circumvent metabolic dysfunction. The impact of any given disease risk factor will vary from person-to-person depending on their background, diabetes-related propensity, and environmental exposures. Defining the consequent heterogeneity within diabetes through precision medicine, both in terms of diabetes risk and risk of complications, could improve health outcomes today and shine a light on avenues for novel therapy in the future.

Citing Articles

Judged by your neighbors: Brain structural normativity profiles for large and heterogeneous samples.

Leenings R, Winter N, Ernsting J, Konowski M, Holstein V, Meinert S medRxiv. 2025; .

PMID: 39763571 PMC: 11703290. DOI: 10.1101/2024.12.24.24319598.


Integrating Polygenic Risk Scores (PRS) for Personalized Diabetes Care: Advancing Clinical Practice with Tailored Pharmacological Approaches.

Singh O, Verma M, Dahiya N, Senapati S, Kakkar R, Kalra S Diabetes Ther. 2024; 16(2):149-168.

PMID: 39688777 PMC: 11794728. DOI: 10.1007/s13300-024-01676-6.


Biobanking for health in Latin America: a call to action.

Rivera-Alcantara J, Aguilar-Salinas C, Martagon A Lancet Reg Health Am. 2024; 41:100945.

PMID: 39583187 PMC: 11585829. DOI: 10.1016/j.lana.2024.100945.


Tailoring cell therapies for diabetic metabolic phenotypes: a comparative study on the efficacy of various umbilical cord-derived cell regimens.

Wang L, Wang L, He F, Song J, Qiao J, Qin J Stem Cells Transl Med. 2024; 14(2).

PMID: 39560969 PMC: 11878779. DOI: 10.1093/stcltm/szae083.


Risk Evaluation of Progression of Proteinuria and Renal Decline Based on a Novel Subgroup Classification in Chinese Patients with Type 2 Diabetes.

Wang K, Qian Q, Bian C, Sheng P, Zhu L, Teng S Diabetes Ther. 2024; 16(1):89-102.

PMID: 39556310 PMC: 11759728. DOI: 10.1007/s13300-024-01667-7.